420 related articles for article (PubMed ID: 21884699)
1. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
4. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
Sachdev U; Cui X; Tzeng E
J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.
Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q
PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677
[TBL] [Abstract][Full Text] [Related]
8. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
9. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
11. Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation.
Moraes TR; Veras FP; Barchuk AR; Nogueira ESC; Kanashiro A; Galdino G
Front Immunol; 2024; 15():1303937. PubMed ID: 38384464
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box 1 protein interacts with multiple Toll-like receptors.
Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
[TBL] [Abstract][Full Text] [Related]
13. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
[TBL] [Abstract][Full Text] [Related]
16. Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.
Vetreno RP; Qin L; Crews FT
Neurobiol Dis; 2013 Nov; 59():52-62. PubMed ID: 23867237
[TBL] [Abstract][Full Text] [Related]
17. The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.
Dvoriantchikova G; Hernandez E; Grant J; Santos AR; Yang H; Ivanov D
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7187-94. PubMed ID: 21828158
[TBL] [Abstract][Full Text] [Related]
18. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.
Zong M; Bruton JD; Grundtman C; Yang H; Li JH; Alexanderson H; Palmblad K; Andersson U; Harris HE; Lundberg IE; Westerblad H
Ann Rheum Dis; 2013 Aug; 72(8):1390-9. PubMed ID: 23148306
[TBL] [Abstract][Full Text] [Related]
19. [Effect of high mobility group box 1 (HMGB1) in cultured human periodontal ligament cells].
Hasegawa N
Kokubyo Gakkai Zasshi; 2008 Oct; 75(3):155-61. PubMed ID: 19044016
[TBL] [Abstract][Full Text] [Related]
20. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
